Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China · Delayed Price · Currency is CNY 3.750
+0.040 (1.08%)
Feb 24, 2026, 3:04 PM CST
SHE:300267 Revenue
Hunan Er-Kang Pharmaceutical had revenue of 324.54M CNY in the quarter ending September 30, 2025, with 39.32% growth. This brings the company's revenue in the last twelve months to 1.29B, up 8.36% year-over-year. In the year 2024, Hunan Er-Kang Pharmaceutical had annual revenue of 1.14B, down -36.09%.
Revenue (ttm)
1.29B
Revenue Growth
+8.36%
P/S Ratio
5.92
Revenue / Employee
889.02K
Employees
1,453
Market Cap
7.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.14B | -643.51M | -36.09% |
| Dec 31, 2023 | 1.78B | -87.42M | -4.67% |
| Jan 1, 2023 | 1.87B | -364.76M | -16.32% |
| Jan 1, 2022 | 2.24B | -146.97M | -6.17% |
| Dec 31, 2020 | 2.38B | -362.07M | -13.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.85B |
| China Animal Husbandry Industry | 6.28B |
| Cisen Pharmaceutical | 3.56B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Shandong Wit Dyne Health | 2.36B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 1.94B |